These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 34306)

  • 1. [Correlations between chemical structure and cardiac effectivity of a group of beta-receptor blockaders].
    Bercher H; Siegmund W; Grisk A
    Acta Biol Med Ger; 1978; 37(7):1081-90. PubMed ID: 34306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Action of alpha- and beta-adrenergic blockaders on the effects of isadrin and noradrenaline in narcotized rats].
    Noravian OS; Abakian OM
    Zh Eksp Klin Med; 1978; 18(1):57-62. PubMed ID: 25545
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA; Stokes GS; Gain JM
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The central action of drugs affecting beta-adrenergic receptor. IV. The influence of intraventricularly administered drugs affecting beta-adrenergic receptor on blood pressure in rats.
    Kleinrok Z; Ksiazek A
    Pol J Pharmacol Pharm; 1975; 27(2):177-82. PubMed ID: 239397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anterior hypothalamic beta-adrenoceptors in chronic aortic-coarctated hypertensive rats: an interaction with central angiotensin II receptors.
    Höcht C; Opezzo JA; Gironacci MM; Peña C; Taira CA
    Clin Exp Pharmacol Physiol; 2005; 32(1-2):30-4. PubMed ID: 15730431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta adrenolytic activity and hemodynamic effects of penbutolol].
    Boissier JR; Coutte R; Advenier C; Giudicelli JF
    Therapie; 1973; 28(6):1251-65. PubMed ID: 4152643
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-adrenoreceptor blocking properties of new thienylethanolamine derivatives.
    Darias V; Madroñero R; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1751-6. PubMed ID: 4155632
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade of cardiac effects of isoproterenol by 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172).
    Somani P; Laddu AR
    J Pharmacol Exp Ther; 1969 Nov; 170(1):72-8. PubMed ID: 4390814
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of cardiac beta-receptors. Studies by means of dose-effect-curves of isoprenaline, propranolol and KL 255].
    Holtermann W; Lochner W
    Arzneimittelforschung; 1970 Jan; 20(1):8-12. PubMed ID: 4392501
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation.
    Lucchesi BR; Hodgeman RJ
    J Pharmacol Exp Ther; 1971 Jan; 176(1):200-11. PubMed ID: 4398216
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of isoproterenol on blood pressure and heart rate in different phases of the oestrous cycle.
    Cirić O; Susić D
    Endokrinologie; 1980 Dec; 76(3):274-8. PubMed ID: 7193571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y; Sakuma I; Nakao Y; Kanno M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956): a nonadrenergic myocardial stimulant.
    Osborne MW; Wenger JJ; Moe RA
    J Pharmacol Exp Ther; 1971 Jan; 176(1):174-83. PubMed ID: 4398214
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
    Wiśniewska RJ; Wiśniewski K
    Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective beta adrenergic receptor antagonism in the anesthetized dog.
    Wasserman MA; Levy B
    J Pharmacol Exp Ther; 1974 Feb; 188(2):357-67. PubMed ID: 4149462
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the beta receptor blocking properties of two analogs of dichloroisoproterenol (DCI).
    Levy B
    J Pharmacol Exp Ther; 1973 Jul; 186(1):123-33. PubMed ID: 4146700
    [No Abstract]   [Full Text] [Related]  

  • 20. The action of ICI-66082 on the heart.
    Harry JD; Knapp MF; Linden RJ
    Br J Pharmacol; 1973 Jun; 48(2):340P-341P. PubMed ID: 4147429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.